Delivery Order SPE2DB25D3012-SPE2DB25FXAEW
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for OxyContin ER 20 mg tablets (100 count) with a ceiling value of $1,768.88. This non-competitive, firm fixed-price delivery order was awarded on June 2, 2025, with an ultimate completion date of June 3, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is performing the work at its corporate office location. This delivery order is executed under AmerisourceBergen's broader Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for OxyContin ER 20 mg tablets (100-count units) valued at $1,066.33 with a firm fixed price structure. The award, issued on September 5, 2025, with an ultimate completion date of September 8, 2025, represents a non-competitive delivery order executed under a larger contract vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of OxyContin ER 20 mg tablets (100 count) valued at $10,845.48 under a firm fixed-price contract. The award, issued on September 24, 2025, with an ultimate completion date of September 25, 2025, was made without a set-aside designation through competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for OxyContin ER 80 mg tablets (100-count units) valued at $5,678.46 under a firm fixed price arrangement. The award, issued on September 18, 2025, with an ultimate completion date of September 19, 2025, represents a competitive procurement with no set-aside designation. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $1,587.64 to AmerisourceBergen Drug Corp for OxyContin ER 20 mg tablets (100-count) on September 5, 2025, with completion expected by September 8, 2025. This is a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for OxyContin ER 10 mg tablets (100-count units) with a ceiling value of $1,365.32. This non-set-aside, firm fixed-price delivery order was awarded on August 6, 2025, with an ultimate completion date of August 7, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract action under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a competitive delivery order to AmerisourceBergen Drug Corp for OxyContin ER 10 mg tablets (100s) with a ceiling value of $1,222.44 and an ultimate completion date of June 20, 2025. This firm fixed price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $1 billion through December 2026. The award was made without set-aside designation, demonstrating...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for OxyContin ER 10 mg tablets (100-count units) with a ceiling value of $1,591.48 and a firm fixed price contract type. The award, issued on September 4, 2025, with an ultimate completion date of September 5, 2025, represents a non-set-aside competitive award to the pharmaceutical distributor's corporate office located in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for OxyContin ER 20 mg tablets (100 count) valued at $2,707.18, with a firm fixed price structure and completion deadline of August 4, 2025. This non-set-aside award, issued on August 1, 2025, represents a single delivery order under the company's existing contract vehicle with DLA. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for OxyContin ER 60 mg tablets (100 count) valued at $1,351.82, with a firm fixed price structure and no set-aside designation. The contract was awarded on July 30, 2025, with an ultimate completion date of July 31, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfilled this order from its corporate office location. This delivery order...
- SPE2DB25D3012Indefinite Delivery Contract
- SPE2DB25D3012-SPE2DB25FXAEWDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for OxyContin ER 60 mg tablets (100 count) with a ceiling value of $17,493.96 under a firm fixed-price arrangement. The award, announced on September 17, 2025, with an ultimate completion date of September 18, 2025, represents a non-set-aside competitive procurement supporting federal medical supply needs. This delivery order is a child contract executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) designated SPE2DX with DLA Troop Support Medical, valued at $999.999 billion and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare systems. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive portfolio under its DLA IDC encompasses brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. As a prime contractor demonstrating capability to compete successfully in open federal procurement, AmerisourceBergen maintains the flexibility to support military and veteran healthcare operations through its comprehensive pharmaceutical supply vehicle while potentially serving as one of multiple regional contractors under the DLA Troop Support's planned Pharmaceutical Prime Vendor Global Program Generation V initiative.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $17.5k | 9/17/25 |